Aarti Pharmalabs (BOM:543748) EPS (Basic): ₹20.57 (TTM As of Mar. 2026)


BOM:543748 Aarti Pharmalabs Ltd BOM:543748
56 GF Score
Price ₹691.50
GF Value ₹636.65
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Aarti Pharmalabs EPS (Basic)?

Aarti Pharmalabs BOM:543748 -2.69% 56 EPS (Basic) is ₹20.57 as of Mar. 2026. GuruFocus rates BOM:543748 with a GF Score™ of 56/100 and a GF Value™ of ₹636.65 (Fairly Valued). The stock has 3 warning signs investors should review.

Aarti Pharmalabs's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹6.74. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹20.57.

Aarti Pharmalabs's EPS (Diluted) for the three months ended in Mar. 2026 was ₹6.74. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹20.57.

Aarti Pharmalabs's EPS without NRI for the three months ended in Mar. 2026 was ₹6.74. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 20.81.

During the past 12 months, Aarti Pharmalabs's average EPS without NRIGrowth Rate was -35.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was -3.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Aarti Pharmalabs's highest 3-Year average EPS without NRI Growth Rate was 30.60% per year. The lowest was -3.00% per year. And the median was 13.80% per year.

Aarti Pharmalabs  (BOM:543748) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Aarti Pharmalabs EPS (Basic) Related Terms

Aarti Pharmalabs EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Aarti Pharmalabs's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aarti Pharmalabs EPS (Basic) Chart

Aarti Pharmalabs Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial 13.49 21.35 23.93 30.06 19.27

Aarti Pharmalabs Quarterly Data
Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.75 5.46 3.08 5.29 6.74
BOM:543748
56GF Score
Aarti Pharmalabs Ltd BOM:543748
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aarti Pharmalabs EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Aarti Pharmalabs's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1747.073-0)/90.663
=19.27

Aarti Pharmalabs's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(611.241-0)/90.689
=6.74

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹20.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹20.57 mean?
Aarti Pharmalabs (BOM:543748) has a EPS (Basic) of ₹20.57 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Aarti Pharmalabs and its competitors.
Is Aarti Pharmalabs' EPS (Basic) too high?
Aarti Pharmalabs' current EPS (Basic) is ₹20.57. Overall, Aarti Pharmalabs has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aarti Pharmalabs' EPS (Basic) compare to ZTS?
Aarti Pharmalabs' EPS (Basic) of ₹20.57 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Aarti Pharmalabs and its competitors. Aarti Pharmalabs's current EPS (Basic) is ₹20.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aarti Pharmalabs stock overvalued right now?
Based on GuruFocus' analysis, Aarti Pharmalabs (BOM:543748) is currently considered Fairly Valued. The stock's GF Value™ is ₹636.65, compared to a current price of ₹691.50 — trading 8.6% above its estimated fair value. The current EPS (Basic) is ₹20.57. Aarti Pharmalabs' overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Aarti Pharmalabs (BOM:543748), the current EPS (Basic) is ₹20.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aarti Pharmalabs (BOM:543748) Overvalued in 2026?

Based on GuruFocus' analysis, Aarti Pharmalabs stock appears to be overvalued. The current stock price of ₹691.50 is trading 8.6% above its estimated GF Value™ of ₹636.65. GuruFocus considers Aarti Pharmalabs to be Fairly Valued.

Key valuation signals for BOM:543748:

  • EPS (Basic): ₹20.57
  • GF Value™: ₹636.65 vs. price of ₹691.50 (8.6% above fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the BOM:543748 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aarti Pharmalabs Business Description

Other Exchanges AARTIPHARM:India
Address Mulund Goregaon Link Road, 204, 2nd Floor, Udyog Kshetra, Mulund West, Mumbai, MH, IND, 400080
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. The company manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, acids, and xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.
56GF Score

Get the complete analysis for BOM:543748

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹691.50
Price
₹636.65
GF Value